INKON Life Technology Co., Ltd.

300143

CNE100000XF6

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-14 EDT			5-day change	1st Jan Change
7.56 ^CNY	-1.95%		-0.26%	-28.88%

04-25	INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-21	INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Starway Bio-technology Co. Ltd. agreed to acquire Hangzhou Zhongwei Chinese Medicine Cancer Hospital Co. Ltd. for CNY 52.8 million.

January 18, 2017

Starway Bio-technology Co. Ltd. (SZSE:300143) agreed to acquire Hangzhou Zhongwei Chinese Medicine Cancer Hospital Co. Ltd. for CNY 52.8 million on January 19, 2017.

Latest news about INKON Life Technology Co., Ltd.

INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-21	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.	04-01	CI
INKON Life Technology Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.	02-05	CI
INKON Life Technology Co., Ltd. authorizes a Buyback Plan.	02-04	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Inkon Life Technology Co., Ltd. Announces Directorate Appointments	23-10-09	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
INKON Life Technology to Set Up Medical Ecological Park for 566 Million Yuan	23-01-18	MT
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. completed the acquisition of Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders.	22-11-13	CI
Qingdao Haiyingkang Investment Co., Ltd. and INKON Life Technology Co., Ltd. agreed to acquire Shenzhen Shengzhong Investment Enterprise (Limited Partnership) from a group of shareholders for CNY 87.7 million.	22-10-26	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
INKON Life Technology Co., Ltd. announced that it expects to receive CNY 999.999998 million in funding from Qingdao Yingkang Medical Investment Co., Ltd.	22-08-11	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-22	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	22-01-11	CI
INKON Life Technology Co., Ltd.'s Equity Buyback announced on February 5, 2021, has expired with 2,509,317 shares, representing 0.39% for CNY 50 million.	22-01-10	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	22-01-04	CI
INKON Life Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Tranche Update on INKON Life Technology Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.	21-10-11	CI
INKON Life Technology Co., Ltd.(XSEC:300143) added to S&P Global BMI Index	21-09-20	CI
Qingdao Yingkang Medical Investment Co., Ltd. acquired Hangzhou Yikang Traditional Chinese Medicine Tumor Hospital Co., Ltd. from INKON Life Technology Co., Ltd. for CNY 1.3 million.	21-09-12	CI

Chart INKON Life Technology Co., Ltd.

Duration

Period

More charts

INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.

Sector

Healthcare Facilities & Services

Calendar

2024-08-22 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for INKON Life Technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.56 CNY

Average target price

10.12 CNY

Spread / Average Target

+33.86%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
INKON LIFE TECHNOLOGY CO., LTD.	-28.88%	661M
AIER EYE HOSPITAL GROUP CO., LTD.	-33.75%	13.43B
IHH HEALTHCARE	+5.14%	11.95B
BANGKOK DUSIT MEDICAL SERVICES	-4.50%	11.66B
APOLLO HOSPITALS ENTERPRISE LIMITED	+13.14%	11.08B
ENCOMPASS HEALTH CORPORATION	+29.65%	8.61B
THE ENSIGN GROUP, INC.	+22.91%	7.63B
MOUWASAT MEDICAL SERVICES COMPANY	+8.05%	6.45B
FORTIS HEALTHCARE LIMITED	+16.63%	4.39B
DALLAH HEALTHCARE COMPANY	-7.45%	4.11B

Hospitals, Clinics & Primary Care Services

INKON Life Technology Co., Ltd.

Equities

300143

CNE100000XF6

Healthcare Facilities & Services

Starway Bio-technology Co. Ltd. agreed to acquire Hangzhou Zhongwei Chinese Medicine Cancer Hospital Co. Ltd. for CNY 52.8 million.

Latest news about INKON Life Technology Co., Ltd.

Chart INKON Life Technology Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for INKON Life Technology Co., Ltd.

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Hospitals, Clinics & Primary Care Services